These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10565998)

  • 1. MEDI 500. Anti-TCR-alpha beta monoclonal antibody T10B9, G 022, T-10B9, T10B9, T10B9 monoclonal antibody, T10B9.1A31, T12A10.
    Drugs R D; 1999 Jan; 1(1):92-4. PubMed ID: 10565998
    [No Abstract]   [Full Text] [Related]  

  • 2. BTI 322. Anti-CD2 monoclonal antibody, Lo-CD2-a, monoclonal antibody Lo-CD2-a.
    Drugs R D; 1999 Jan; 1(1):68-70. PubMed ID: 10565990
    [No Abstract]   [Full Text] [Related]  

  • 3. Inolimomab. Anti-CD25 monoclonal antibody B-B10, anti-interleukin-2 receptor monoclonal antibody B-B10, B-B10, BT 563, Leukotac.
    Drugs R D; 1999 Jan; 1(1):81-4. PubMed ID: 10565995
    [No Abstract]   [Full Text] [Related]  

  • 4. Priliximab. Anti-CD4 MAb, CEN 000029, MT 412, cMT 412, Centara.
    Drugs R D; 1999 Jan; 1(1):95-6. PubMed ID: 10565999
    [No Abstract]   [Full Text] [Related]  

  • 5. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH; Lucas BA; Amlot P; Janossy G; Yacoub M; Cammisuli S; Jezek D; Rhoades J; Brown S; Thompson JS
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
    Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
    Waid TH; Lucas BA; Thompson JS; McKeown JW; Brown S; Kryscio R; Skeeters LJ
    Transplantation; 1997 Jul; 64(2):274-81. PubMed ID: 9256187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

  • 9. FTY 720.
    Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.
    Waid TH; Thompson JS; McKeown JW; Brown SA; Sekela ME
    J Heart Lung Transplant; 1997 Sep; 16(9):913-6. PubMed ID: 9322140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHH 380. Chimeric anti-CD7 antibody, SDZ CHH 380.
    Drugs R D; 1999 Jan; 1(1):73-4. PubMed ID: 10565992
    [No Abstract]   [Full Text] [Related]  

  • 12. Campath-1G. Campath IgG, Campath-1-IgG antibody.
    Drugs R D; 1999 Jan; 1(1):71-2. PubMed ID: 10565991
    [No Abstract]   [Full Text] [Related]  

  • 13. T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action.
    Brown SA; Lucas BA; Waid TH; McKeown JW; Barve S; Jackson LR; Thompson JS
    Clin Transplant; 1996 Dec; 10(6 Pt 2):607-13. PubMed ID: 8996751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T10B9 action: the effect of anti-T-cell antibody mitogenicity and graft rejection on the first dose cytokine response.
    Brown S; Lucas B; Waid T; McKeown W; Tsuchida M; Thompson J
    Transplant Proc; 1997; 29(1-2):315-6. PubMed ID: 9123017
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.
    Waid TH; Lucas BA; Thompson JS; Brown SA; Munch L; Prebeck RJ; Jezek D
    Transplantation; 1992 Jan; 53(1):80-6. PubMed ID: 1531095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDZ RAD. Rapamycin SDZ.
    Drugs R D; 1999 Jan; 1(1):97-9. PubMed ID: 10566000
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
    Norman DJ; Bennett WM; Cobanoglu A; Hershberger R; Hosenpud JD; Meyer MM; Misiti J; Ott G; Ratkovec R; Shihab F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):802-3. PubMed ID: 8438490
    [No Abstract]   [Full Text] [Related]  

  • 18. ISIS 2302. INXC ICAM1, Oligo-TCS.
    Drugs R D; 1999 Jan; 1(1):85-6. PubMed ID: 10565996
    [No Abstract]   [Full Text] [Related]  

  • 19. New monoclonal antibodies to prevent transplant rejection.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):93-4. PubMed ID: 9774964
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients.
    Thompson JS; Pomeroy C; Kryscio RJ; Brown SA; Reece D; Kramer R; Howard DS; VanZant G; Humphries S; Phillips G
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):858-66. PubMed ID: 15570254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.